This study investigates the role of central vs. peripheral factors in the limitation of maximal oxygen uptake (V O2max) with moderate hypoxia [inspired fraction (FI O 2 ) ϭ14.5%]. Fifteen endurance-trained athletes performed maximal cycle incremental tests to assess V O2max, maximal cardiac output (Q max), and maximal arteriovenous oxygen (a-vO2) difference in normoxia and hypoxia. Muscle biopsies of vastus lateralis were taken 1 wk before the cycling tests to evaluate maximal muscle oxidative capacity (V max) and sensitivity of mitochondrial respiration to ADP (Km) on permeabilized muscle fibers in situ. Those athletes exhibiting the largest reduction of V O2max in moderate hypoxia (Severe Loss group: Ϫ18 Ϯ 2%) suffered from significant reductions in Q max (Ϫ4 Ϯ 1%) and maximal a-vO2 difference (Ϫ14 Ϯ 2%). Athletes who well tolerated hypoxia, as attested by a significantly smaller drop of V O2max with hypoxia (Moderate Loss group: Ϫ7 Ϯ 1%), also display a blunted Q max (Ϫ9 Ϯ 2%) but, conversely, were able to maintain maximal a-vO 2 difference (ϩ1 Ϯ 2%). Though V max was similar in the two experimental groups, the smallest reduction of V O2max with moderate hypoxia was observed in those athletes presenting the lowest apparent Km for ADP in the presence of creatine (KmϩCr). In already-trained athletes with high muscular oxidative capacities, the qualitative, rather than quantitative, aspects of the mitochondrial function may constitute a limiting factor to aerobic ATP turnover when exercising at low FIO 2 , presumably through the functional coupling between the mitochondrial creatine kinase and ATP production. This study suggests a potential role for peripheral factors, including the alteration of cellular homeostasis in active muscles, in determining the tolerance to hypoxia in maximally exercising endurance-trained athletes.
HYPOXIC ENVIRONMENTS HAVE repeatedly been observed to depress maximal oxygen uptake (V O 2max ) during whole body exercise in humans, and the magnitude of this reduction is thought to be proportional to the hypoxia-induced diminution of arterial oxygen content (15) . Although this phenomenon is well described, a wide interindividual variability in the magnitude of reduction of V O 2max at a given level of hypoxia has been reported by several laboratories (8, 14, 28, 31, 37) . Of note is the observation that the hypoxia-induced reduction in V O 2max is greater in endurance athletes than in sedentary subjects (28) . However, the mechanisms involved in the fitness-specific limitation of maximal aerobic metabolism with moderate hypoxia [inspired fraction (FI O 2 ) ϭ ϳ14.5% or 2,000 -3,000 m] remain unclear, as changes in oxygen extraction may play a role to maintain arteriovenous oxygen (a-vO 2 ) difference and aerobic power. For instance, despite being the two determinants of V O 2max during whole body exercise in athletes, little is known about the respective contribution of cardiac output (Q ) and a-vO 2 difference in the individual hypoxia tolerance, especially within a homogenous group of endurancetrained athletes.
Maximal Q (Q max ) and systemic oxygen delivery are considered the main limiting factors of V O 2max in normoxia (40) , but experimental and modeling evidences suggest that their implication in setting V O 2max is progressively reduced with hypoxia, to the extent of an increased contribution from peripheral muscle factors (13, 37) . In line with this possibility, recent results have demonstrated that maximal aerobic metabolic rate is maintained in the skeletal muscles of sedentary subjects when arterial oxygen content and delivery are compromised by moderate hypoxia, i.e., FI O 2 ϭ 15% (20) . This observation suggests that skeletal muscle factors involved in blood redistribution and/or oxygen extraction can compensate for the reduction in systemic oxygen delivery to maintain aerobic energy turnover. Such compensatory adjustments do not seem to happen in endurance-trained subjects (19, 21) , and V O 2max starts to fall even at very low levels of hypoxia (FI O 2 ϭ ϳ19.5% or 580 m) (16) . This picture is consistent with the idea that trained subjects have developed their aerobic energy provision pathways to use most of the oxygen supply available to the muscle in the normoxic condition. In turn, this enhancement of muscle oxidative capacity may become a disadvantage in hypoxic conditions, where subtle reductions in O 2 supply are sufficient to limit V O 2max . To date, the potential role of skeletal muscle mitochondrial function in the maintenance of maximal a-vO 2 difference and V O 2max in hypoxia has never been investigated.
Two fundamental properties of mitochondrial function play a central role in determining the maximal capacities of aerobic energy transfers in skeletal muscle. On one hand, the maximal rate of mitochondrial respiration is mainly related to the mitochondrial content and oxidative enzyme activities of the skeletal muscle cells. On the other hand, the intimate regulation of mitochondrial activation is underlined by the intrinsic properties of the mitochondrial pool and by the ability of the mito-chondria to communicate with their subcellular environment. A low sensitivity of mitochondrial respiration to cytosolic ADP and a high control of respiration by the creatine kinase (CK) shuttle system, with mitochondrial CK (mi-CK) as the ultimate element, are now clearly established as a hallmark of fatigueresistant oxidative muscles (27, 43) . In this condition, mitochondrial respiration is no more set by cytosolic ADP levels but by the local creatine phosphate/creatine (PCr/Cr) ratios (45) . Increasing aerobic performance is then associated with a reorganization of the muscle fibers' cytoarchitecture, including quantitative and qualitative mitochondrial adaptations (52, 62, 63). Such changes are expected to limit perturbations of cellular homeostasis like the decrease of the ATP/ADP ratio and to delay the contribution of anaerobic glycolysis to energy supply. While a greater homeostasis disturbance has been shown to occur during hypoxic vs. normoxic exercise (22, 24, 49) , little is known about the potential contribution of quantitative and qualitative properties of the skeletal muscle mitochondrial function in the tolerance to hypoxia during maximal exercise (i.e., V O 2max ) in endurance-trained athletes.
Using a cross-sectional design, the present study investigates the role of mitochondrial function in the hypoxia-induced limitation of V O 2max in a group of homogenous endurancetrained athletes. We hypothesized that the attenuation of V O 2max with moderate hypoxia in endurance-trained athletes is related to their ability to maintain maximal a-vO 2 difference and is associated with qualitative and quantitative properties of their skeletal muscle function.
MATERIAL AND METHODS

Ethical Approval
All subjects gave their written consent to participate in the study and were fully informed about its potential risks. The study conformed to the code of Ethics of the World Medical Association (Declaration of Helsinki) and was approved by the Ethics Committee for Strasbourg's Hôpital Civil, in accordance with French law.
Subjects
Fifteen male endurance runners and triathletes (age: 31 Ϯ 2 yr; height: 179 Ϯ 1 cm; weight: 69.8 Ϯ 1.3 kg; V O2max: 58.6 Ϯ 1.7 ml·min Ϫ1 ·kg Ϫ1 ) completed the study (Table 1 ). All were highly motivated to participate in the study and engaged in competitive endurance running events for Ͼ 5 yr, with the current 10,000 m or equivalent personal best times of Ͻ 35:00 (min/s).
Study Design
Basal examination. Two weeks before the experiment, each subject came to the laboratory for anthropometric measurements, physical examination, forearm venous blood sampling, resting electrocardiography, and echocardiography recordings. All results were within normal limits.
Cycling incremental test to exhaustion. The exercise tests were performed in the upright position on an electronically braked cycle ergometer (Medifit 1000S). Incremental tests to exhaustion were performed by each subject to determine the ventilatory thresholds (VTs) and V O2max in two experimental conditions: 1) at sea level (FIO 2 ϭ 21%) and 2) at simulated altitude (FIO 2 ϭ 14.5%; ϳ3,000 m). The tests were randomly balanced and separated by 24-h rest.
Skeletal muscle biopsy. Vastus lateralis muscle biopsies were taken by the percutaneous Bergström technique under local anesthesia (lidocaine/lignocaine) within 1 wk prior to the cycling tests. No complications occurred following biopsies in any subject.
Procedures
Exercise tests. Incremental tests to exhaustion began at 80 W, and the power output was subsequently increased by 40 W every 2 min until exhaustion. Pedal frequency was maintained constant at 60 -70 rpm during the test and each subject was encouraged to give a maximum effort.
VTs were assessed using established criteria (7, 48) . VT 1 corresponds to the breakpoint in the plot of carbon dioxide output (V CO2) as a function of V O2. At that point, the ventilatory equivalent for O2 (V E/V O2) increases without an increase in the ventilatory equivalent for CO2 (V E/V CO2). VT2 was located between VT1 and V O2max, when V E/V CO2 starts to increase, while V E/V O2 continues to increase. V O2max was defined as the highest 30-s averaged V O2 value. Most subjects had a 1-min or more V O2 leveling off at maximal exercise (Table 2) as criteria for V O2max, and all attained at least two of the following criteria: 1) a maximal heart rate Ͼ 90% of the predicted maximal heart rate, 2) a lactate level at maximal exercise of Ͼ 8 mmol/l, or 3) a respiratory exchange ratio at peak exercise Ͼ 1.10.
Gas exchange measurements. V O2 and V CO2 were measured breath-by-breath with an open-circuit metabolic cart (Sensor Medics MSE, Yorba Linda, CA). The pneumotachograph used a hot-wire technology and was calibrated before each test with several strokes given by a 3-liter calibration syringe. The gas analyzers were calibrated using reference gases with known O 2 and CO2 concentrations (12% O2-5% CO2). The accuracy of gas analyzers were verified monthly against a metabolic simulator.
Cardiovascular measurements. Stroke volume was measured by bioimpedance, whereas heart rate was simultaneously estimated from the electrocardiogram first derivative (Manatec type PF05L1; Physio Flow, Paris, France). The accuracy of this bioimpedance device has previously been established against the direct Fick method during maximal incremental exercise in healthy subjects (36) . Calibration of the impedance device was done using a procedure based on 24 consecutive heartbeats recorded with the subject resting on the ergometer (10). Arterial oxygen saturation was monitored by pulse oximetry at the earlobe; a-vO 2 was calculated as the V O2/Q ratio.
Blood analyses. Blood samples were obtained as part of the basal examination from an antecubital vein of the forearm for hemoglobin and hematocrit measurement (model ABL 700; Radiometer, Copenhagen, Denmark). Additional blood samples were taken from the arterialized earlobe at exhaustion immediately after each maximal cycle exercise test for total blood lactate determination by an enzymatic method. ; V O2max, maximal oxygen uptake determined in the normoxic test; Ppeak, peak pressure; Q max, maximal cardiac output; a-vO2, arteriovenous oxygen; NS, not significant. Ventilatory threshold-1 (VT1) and VT2 were determined during the normoxic test.
In situ study of mitochondrial respiration. The mitochondrial respiration was studied in situ in a bundle of separated saponin skinned fibers as previously described (39, 44) . Briefly, fibers were separated under binocular microscope in solution S at 4°C (see below) and permeabilized in solution S with 50 g/ml of saponin for 30 min. After being placed 10 min in solution R (see below) to wash out adenine nucleotides and PCr, skinned separated fibers were transferred into a 3-ml water-jacketed oxygraphic cell (Strathkelvin Instruments, Glasgow, Scotland) equipped with a Clark electrode as previously described (33) . Fiber respiration rates were measured at 22°C under continuous stirring. ADP-stimulated respiration (V ADP) above V 0 was measured by stepwise addition of ADP as phosphate acceptor (from 10 to 2,000 M) with or without Cr (20 mM). The decrease in O 2 concentration vs. time within the oxygraphic cell gave a measure of the respiration rate in micromoles oxygen per minute, subsequently expressed per gram of dry weight muscle tissue. The apparent K m values for ADP were calculated by using a nonlinear monoexponential fitting of the Michaelis-Menten equation (K m ϭ no Cr in the oxygraphic cell; KmϩCr ϭ 20 mM Cr in the oxygraphic cell). Nonlinear fitting (Microsoft Excel, Redmond, WA) for Km assessment in skinned muscle fibers is an already established fitting method, giving consistent results and yielding correlation coefficients Ն 0.99 for each measurement. Moreover, it gives an equal weight to each experimental measurement, avoiding the disadvantages of linear fitting that overweight the extreme points compared with the others. Maximal respiration rate (V max) was calculated as (V ADP ϩ V 0). The acceptor control ratio (ACR) was calculated as V max/V 0.
Both solutions R and S contained: 2.77 mM CaK2 EGTA, 7.23 mM K2 EGTA (100 nM free Ca 2ϩ ), 6.56 mM MgCl2 (1 mM free Mg 2ϩ ), 20 mM taurine, 0.5 mM DTT, 50 mM K-methane sulfonate (160 mM ionic strength), 20 mM imidazole (pH 7.1). Solution S also contained 5.7 mM Na 2ATP and 15 mM PCr. Solution R contained 3 mM phosphate, 2 mg/ml fatty acid-free bovine serum albumin, 2 mM malate, and 5 mM glutamate. After the experiments, fibers were harvested, dried, and weighed to express respiration rates as micromole O 2 per minute per gram dry weight.
Group Assignment
For each subject, the difference between the V O2max values measured in normoxia and hypoxia was calculated (⌬V O2max). In the whole population, the mean ⌬V O2max was 7. ).
Statistics
Statistical analyses were performed using Sigma Stat for Windows (version 3.0; SPSS, Chicago, IL). The differences between groups (SL vs. ML) were tested using Student's t-test (mitochondrial parameters) and two-way ANOVA for repeated measures followed by a StudentNewman-Keuls post hoc procedure (exercise data). Spearman analysis was used to determine any potential relationship between variables. Data are means Ϯ SE. Differences were considered to be significant for P Յ 0.05. Table 1 , no difference was observed between groups for the anthropometric characteristics blood hemoglobin and hematocrit. Normoxic aerobic function was also similar, with equivalent V O 2max , Q max , and maximal a-vO 2 difference; and no differences were observed between groups at VT 1 and VT 2.
RESULTS
As shown in
Effect of Hypoxia on Metabolic and Cardiovascular Responses to Maximal Exercise
By design, the hypoxia-induced limitation of V O 2max was greater in the SL vs. the ML group, with reductions of Ϫ18 Ϯ 2 vs. Ϫ7 Ϯ 1%, respectively (P Ͻ 0.05; Fig. 1 and Table 2 ). No significant correlation was found between the absolute reduction of V O 2max and V O 2max measured in normoxia (r ϭ 0.37; P ϭ 0.17). Both groups displayed similar levels of arterial oxygen desaturation with hypoxia (Ϫ15%, P Ͻ 0.05). Q max was attenuated by hypoxia, with the SL group tending to exhibit a smaller decrease than the ML group (Ϫ4 Ϯ 1 vs. Ϫ9 Ϯ 2%, respectively; P ϭ 0.08). As a mirror image, maximal a-vO 2 difference was impaired by Ϫ14 Ϯ 2% with hypoxia in the SL group but was maintained in the ML group (Ϫ1 Ϯ 2%; P Ͻ 0.05 between groups). Although significant in the SL group only, hypoxia tended to reduce maximal heart rate, whereas maximal stroke volume was never significantly altered (Fig. 2 ). An overview of these results is given in Fig. 3 . Maximal blood lactate concentration was not different between groups either in normoxia (SL: 13.6 Ϯ 1.8 vs. ML: 12.1 Ϯ 0.8 mmol/l; not significant) or in hypoxia (SL: 12.9 Ϯ 1.2 vs. ML: 11.2 Ϯ 1.1 mmol/l; not significant).
Effect of Hypoxia on Metabolic and Cardiovascular Responses to Submaximal Exercise
As shown in Fig. 1, V O 2 was similar during submaximal exercise in both conditions of oxygen availability. Q was not modified by hypoxia at submaximal exercise in the ML group, whereas the SL group displayed an enhanced Q response in hypoxia at any given workload. A greater heart rate appears to be the main mechanism underlying the enhanced Q response observed in the SL group. By contrast, stroke volume was similar in normoxia and hypoxia in both groups (Fig. 2) . As a result of the greater hypoxic Q response in the SL group, a-vO 2 difference was lower at any given workload. Of note, a-vO 2 difference tended to be higher in hypoxia in the ML group (Fig. 1) . 
Values are means Ϯ SE. ⌬V O2max ϭ V O2max measured during the normoxic test Ϫ V O2max measured during the hypoxic test. ⌬Maximal a-vO2 difference, maximal a-vO2 difference measured during the normoxic test Ϫ maximal a-vO2 difference measured during the hypoxic test. *Significantly different from normoxia (P Ͻ 0.05). †Significantly different from the Severe Loss group (P Ͻ 0.05).
Mitochondrial Function
As indicated in Table 3 , the quantitative parameters of mitochondrial function (V 0 , V max , ACR) were not significantly different between groups. V max was neither correlated to V O 2max measured in normoxia (r ϭ 0.41; P ϭ 0.12) nor to ⌬V O 2max (r ϭ 0.36; P ϭ 0.18). Conversely, significant differences appeared for the qualitative properties, reflecting the role of mi-CK in oxidative phosphorylation coupling. Indeed, K mϩCr was lower in ML compared with SL, whereas the K m /K mϩCr ratio was higher. K m for ADP without Cr was not different between groups. When all subjects were pooled together, K mϩCr was positively correlated to ⌬maximal a-vO 2 difference (r ϭ 0.52; P ϭ 0.05) (Fig. 4) . The K m -to-K mϩCr ratio was negatively correlated to ⌬V O 2max (r ϭ Ϫ0.53; P ϭ 0.03) and ⌬maximal a-vO 2 difference (r ϭ Ϫ0.55; P ϭ 0.03) (Fig. 4) .
DISCUSSION
Major Findings
This study suggests that the individual magnitude of the hypoxia-induced reduction of V O 2max in a homogenous group of endurance-trained athletes is accounted for by specific responses of central and peripheral factors involved in O 2 delivery, extraction, and processing at the cellular level. Those athletes exhibiting the largest reduction of V O 2max in moderate hypoxia suffer from both significant reductions in Q max and maximal a-vO 2 difference together with a lower degree of coupling between CK shuttle and oxidative phosphorylation at the mitochondrial level. Conversely, athletes presenting the smallest attenuation of V O 2max with moderate hypoxia are able to maintain maximal a-vO 2 difference despite a blunted Q response and reveal a higher coupling of the CK shuttle. This Fig. 1 . Group responses of oxygen uptake (V O2), cardiac output (Q ), and arteriovenous O2 (a-vO2) difference to incremental exercise in normoxia and moderate hypoxia. The last 2 points represent data at maximal exercise. *P Ͻ 0.05 vs. hypoxia; $P Ͻ 0.001 vs. moderate hypoxia. Due to technical difficulties, Q and a-vO2 difference are missing for 1 subject. Therefore, these data are presented for n ϭ 14 subjects.
suggests that the functional coupling between ATP production and the CK shuttle appears to play a role in the maintenance of V O 2max as close as possible to its normoxic level when exercising in moderate hypoxia.
Attenuation of oxygen uptake and extraction during maximal exercise in moderate hypoxia. Both groups present a similar V O 2max in normoxia (P ϭ 0.25), and exercise in moderate hypoxia (i.e., FI O 2 ϭ 14.5% or ϳ3,000 m) reduced the normoxic V O 2max by ϳ12 Ϯ 2% in the whole population. This value falls within the range of previously published values reporting attenuations of V O 2max between Ϫ9 and Ϫ20% in this setting (6, 8, 26, 31, 37) . A closer analysis of our data demonstrates quite large interindividual variability in the V O 2max response to hypoxia, with ⌬V O 2max presenting a coefficient of variation of 36% between subjects. Numerous factors have been proposed to account for the reduction of V O 2max with hypoxia and its variability (6), and their integrated effects can be approached by focusing on the convection (i.e., Q , arterial Fig. 2 . Group responses of heart rate and stroke volume to incremental exercise in normoxia and moderate hypoxia. The last 2 points represent data at maximal exercise. *P Ͻ 0.05 vs. hypoxia; $P Ͻ 0.001 vs. moderate hypoxia. Due to technical difficulties, stroke volume is missing for 1 subject. Therefore, these data are presented for n ϭ 14 subjects. oxygen content) and diffusion steps (i.e., alveolar to arterial, capillary to myocytes) involved in O 2 delivery and O 2 extraction.
The present results show that moderate hypoxia blunted both Q max and maximal a-vO 2 difference in the SL group, ultimately reducing normoxic V O 2max by ϳ18%. Although a similar decrease in Q max was also observed in the ML group, a new finding of the present study is that maximal a-vO 2 difference was better maintained in this group, allowing V O 2max to be only 7% lower under moderate hypoxia compared with its normoxic value. Such specific group responses were also identified at submaximal exercise, where athletes of the SL group displayed the well-known elevation of heart rate and Q at any given power output to compensate for the reduction in a-vO 2 difference (41) imposed by hypoxia. Conversely, athletes from the ML group tend to have a lower cardiovascular response (i.e., Q , heart rate, and stroke volume) together with an increased a-vO 2 difference, allowing them to maintain aerobic energy turnover at submaximal exercise. Such compensatory adjustments between Q and maximal a-vO 2 difference have already been reported after ␤-adrenergic blockade in normoxia but also in severe hypoxia (4,300 m or FI O 2 ϭ ϳ12.5%), where the drug-induced limitation in heart rate and Q were compensated for by elevations in a-vO 2 difference and O 2 extraction at submaximal (50) and maximal exercise (28) , allowing maintenance of oxygen uptake. Taken together, these results suggest that factors improving systemic O 2 extraction, either directly or more likely by reflex modification of blood flow redistribution, could compensate for the reduced systemic O 2 delivery. In support of this, we observed that ⌬V O 2max was significantly correlated with ⌬maximal a-vO 2 difference but not with ⌬Q max nor with ⌬Sa O 2 . The central components of systemic O 2 delivery then appear unlikely to have played a major role in setting the individual tolerance to moderate hypoxia in our athletes (also displaying similar blood hemoglobin content), further pointing to a key role of downstream factors, within the active locomotor muscles. O 2 extraction is already known to be higher at maximal exercise in hypoxia vs. normoxia in an attempt to compensate for the reduction in arterial O 2 content (46). However, maximal a-vO 2 difference is usually reduced with hypoxia (31), mainly because of its critical dependence on arterial O 2 content. Therefore, the unique result of an unchanged maximal a-vO 2 difference in the ML group may be specific to moderate hypoxia, where venous O 2 content can be further lowered to compensate for the modest reduction in arterial O 2 content. The ability to enhance O 2 extraction with hypoxia has been advanced as a plausible mechanism explaining part of the better tolerance to altitude observed in untrained vs. trained subjects (35) , but the underlying mechanisms remain unclear. A preferential redistribution of blood flow toward locomotor muscles, either by increasing red blood cell flow in already perfused capillaries and/or recruiting previously nonperfused capillaries (9, 35) , together with the properties of the skeletal muscle mitochondrial function, might contribute to improving capillary-myocyte O 2 exchange with moderate hypoxia.
Maintenance of V O 2max and maximal a-vO 2 difference in hypoxia is not linked to quantitative aspects of mitochondrial function.
In conditions where O 2 delivery is reduced, the question of what is/are the factor(s) involved in O 2 extraction is still open, and the role of the mitochondria in this setting remains unclear. Some studies suggest that the major cause for the reduced muscle O 2 consumption in hypoxia is O 2 availability in the surroundings of the mitochondria rather than skeletal muscle oxidative capacities (21, 27, 44, 56) . Other studies suggest that both oxygen supply and mitochondrial oxidative capacities interact to determine V O 2max (23, 25) . Interestingly, our measures of mitochondrial respiration in situ (V max ) showed that high maximal muscle oxidative capacity, which is likely to reflect the mitochondrial density, might not be critical to attenuate the hypoxia-related reduction of V O 2max and maximal a-vO 2 difference in already endurance-trained athletes. In a previous study, we showed that V max was positively correlated to V O 2max when the population ranges from sedentary (V O 2max ϭ 28.5 ml·kg Ϫ1 ·min Ϫ1 ) to moderately trained subjects (V O 2max ϭ 50 ml·kg Ϫ1 ·min Ϫ1 ) (51). However, in subsequent studies, endurance athletes with higher V O 2max (ϳ60 ml·kg Ϫ1 ·min Ϫ1 ) were shown to have similar V max values compared with their moderately trained counterparts (12, 34) , suggesting that the quantitative aspects of tissue oxidative capacity levels off before the highest levels of endurance training are reached. Moreover, the higher V O 2max demonstrated by endurance-trained athletes was not accompanied by any increase in enzymatic markers of quantitative aspects of mitochondrial function (34) . In the present study, the ACR was similar between groups, suggesting that the degree of coupling between electron transport and phosphorylation does not explain the difference in the ability to maintain the normoxic V O 2max in moderate hypoxia.
Intrinsic qualitative mitochondrial properties correlate with a better maintenance of V O 2max and maximal a-vO 2 difference during exercise in moderate hypoxia. The combination of increased mitochondrial content and oxidative capacities together with specific reorganization of intracellular energy fluxes is known to be an integral part of the adaptation to endurance training (40, 55, 58, 63) . Accordingly, the apparent K m to ADP (inversely proportional to the apparent affinity of mitochondria for ADP) was high in all our athletes, regardless of the magnitude of their drop in V O 2max with moderate hypoxia, suggesting that the sensitivity to cytosolic ADP is not a key factor involved in the hypoxia tolerance in athletes with already high K m values. Nevertheless, high K m values reflect a low sensitivity of mitochondrial respiration to cytosolic ADP, as expected in endurance-trained subjects (34, 47, 51) with skeletal muscles featuring high oxidative capacities (8, 31, 48, 53, 55, 62) .
However, other qualitative properties of the muscular mitochondria may contribute to maintain V O 2max close to its normoxic value in athletes exercising in moderate hypoxia. In support for this contention, we report for the first time that the ability to keep high levels of V O 2max and maximal a-vO 2 difference during moderate hypoxic exercise is correlated with the decrease of the K m for ADP in the presence of Cr (lower K mϩCr , higher K m /K mϩCr ratio). The coupling between mi-CK and oxidative phosphorylation might then play a role in the limitation of V O 2max with hypoxia. In that way, the phosphate moiety is transferred more efficiently to PCr, and ADP is more rapidly recycled toward oxidative phosphorylation, so that a smaller cellular ADP signal is necessary to stimulate mitochondrial O 2 uptake and muscle O 2 extraction. In intact muscle, where mi-CK is active and coupled, it is the PCr/Cr ratio that triggers mitochondrial respiration rather than the ADP/ATP ratio. It has already been suggested in cardiomyocytes that mitochondrial intrinsic regulation can compensate for relatively slow oxygen diffusion (42) . Skeletal muscles with higher coupling between mi-CK and ADP rephosphorylation produce energy on a "pay as you go" basis and therefore may be able to maintain longer the cellular homeostasis in conditions of lower O 2 availability during an incremental test. This may delay the use of anaerobic energy production while exercising at low FI O 2 , thereby maintaining a more favorable intracellular redox potential and producing less metabolite by-products until a final level of peripheral muscle fatigue develops and exhaustion occurs (4, 5, 38) . Because V O 2max in normoxia and hypoxia ultimately represents an O 2 flow, in part driven by the potential to extract O 2 from capillary blood, the link between the smaller attenuation of V O 2max and the ability to maintain the cellular redox potential under moderate hypoxia remains unclear at present.
With hypoxia, the well-known greater metabolite accumulation (H ϩ , P i , lactate, ADP, adenosine, ATP, bradykinin, etc.) in active muscles and their interstitial surroundings (11) has been proposed to exacerbate the stimulation of group III and IV muscle afferents ultimately resulting in a cessation of central motor output and exhaustion (29) . How exactly the reduced central motor output occurs is still a matter of debate. Higher plasma catecholamine and muscle sympathetic nerve activity have been documented with hypoxia (17, 18) , triggering peripheral sympathetic vasoconstrictor activity that overrides vasodilatory stimuli generated within the active limbs, particularly at maximal exercise. In support of this mechanism, exhaustion during maximal incremental exercise in normoxia is associated with increasing mean arterial pressure and falling systemic and leg vascular conductance (32) . Of note, intraarterial femoral ATP injection reduces mean arterial pressure in hypoxia but not in normoxia during maximal cycle exercise, suggesting the prevalence of a higher level of vasoconstriction in hypoxia (30) . Moreover, experimental evidence for a critical role of somatosensory feedback in fatigue during maximal exercise has accumulated recently (1-3), further pointing to a key role of cellular homeostasis disturbance in limiting aerobic exercise capacity. In the present study, a lower disturbance in intracellular energetics in muscles with highly coupled mitochondria may delay muscle afferent activation involved in sympathetic activation and local vasoconstriction. The lower heart rate for a given power output in the ML group also fits with this hypothesis.
Limitations of the Study
The SL group exhibited a somewhat greater normoxic V O 2max compared with the ML group, suggesting a risk for a type 2 error with our small number of subjects. Despite P values always Ͼ 0.27, significant differences would not have changed the main conclusions of this study, which, for the first time, provides evidence for a role of skeletal muscle mitochondria in the tolerance to moderate hypoxia in endurance-trained athletes. Moreover, whatever the level of statistical significance for mitochondrial V max between the two groups, the magnitude of the difference clearly points to qualitative (K m ϭ 9%; K mϩCr ϭ 48%; K m ratio ϭ 100%), rather than quantitative, adaptations (V max ϭ 9%) as major mitochondrial properties involved in hypoxia tolerance. Nevertheless, the present data do not allow further insights into the mechanisms linking mitochondrial properties to the hypoxia-mediated reduction in V O 2max . Another limitation of the present study is the use of cardiac impedance to estimate stroke volume and calculate Q . Nevertheless, this noninvasive methodology has been validated by our and other laboratories and is currently largely used in exercise physiology, especially in trained and lean subjects where good thoracic impedance signals can be collected. The same technique has been applied to all subjects in the present study, and a closer analysis of our hemodynamic data reveals that the main difference between the SL and the ML groups are heart rate mediated and therefore do not rely on the stroke volume measurement. Therefore, the conclusions reported in the present report are not likely to be methodology dependent.
Perspective and Significance
The individual tolerance to moderate hypoxia is quite variable from one subject to another, even among endurancetrained athletes with similar V O 2max . A better knowledge of the mechanisms involved in the hypoxia-induced limitation of V O 2max could help in setting optimal support for mountaineers or competitive athletes preparing for exercises at a moderate altitude. Whereas the blunting of Q max seems a universal response to moderate hypoxia, we observed a smaller hypoxiainduced attenuation of V O 2max in those athletes able to maintain their maximal a-vO 2 difference. Additionally, high qualitative (i.e., intrinsic regulation) rather than quantitative (i.e., maximal oxidative capacity) properties of skeletal muscle mitochondria are characteristics of endurance-trained athletes, featuring the better tolerance to moderate hypoxia. Future studies will need to explore how a greater functional coupling between the mi-CK and ATP production, and therefore, a better control of the skeletal muscle cellular homeostasis may contribute to the individual tolerance to moderate hypoxia in endurance-trained athletes.
